BRUSSELS (Reuters) – U.S. agency Johnson & Johnson is prone to apply for EU approval for its COVID-19 vaccine candidate in February, a prime lawmaker mentioned on Wednesday.
“EU Well being Commissioner Stella Kyriakides introduced throughout our (EU lawmakers) group assembly this morning that the vaccine producer Johnson & Johnson is prone to submit an utility for approval to the EU for his or her vaccine in February,” mentioned Peter Liese, who represents well being issues for the EU’s centre-right group, the meeting’s largest.
The EU medicine regulator had mentioned in December it anticipated the corporate to use within the first quarter of this yr.
The European Medicines Company began on Dec. 1 a rolling evaluate of the vaccine, which Johnson & Johnson is growing via its subsidiary Janssen.
The EU has booked 200 million doses of the J&J vaccine and has an choice to order one other 200 million pictures. The J&J vaccine requires a single dose, not like different vaccines accepted to date within the EU and which require two doses for full safety.
Reuters Well being Info © 2021
Cite this: J&J More likely to Apply for EU Approval for COVID Vaccine in February: Lawmaker – Medscape – Jan 13, 2021.